M. Gurbuz Et Al. , "Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer," TUMORI JOURNAL , vol.107, no.5, pp.416-423, 2021
Gurbuz, M. Et Al. 2021. Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer. TUMORI JOURNAL , vol.107, no.5 , 416-423.
Gurbuz, M., AKKUŞ, E., Sakin, A., Urvay, S., Demiray, A. G., Sahin, S., ... Sakalar, T.(2021). Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer. TUMORI JOURNAL , vol.107, no.5, 416-423.
Gurbuz, Mustafa Et Al. "Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer," TUMORI JOURNAL , vol.107, no.5, 416-423, 2021
Gurbuz, Mustafa Et Al. "Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer." TUMORI JOURNAL , vol.107, no.5, pp.416-423, 2021
Gurbuz, M. Et Al. (2021) . "Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer." TUMORI JOURNAL , vol.107, no.5, pp.416-423.
@article{article, author={Mustafa Gurbuz Et Al. }, title={Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer}, journal={TUMORI JOURNAL}, year=2021, pages={416-423} }